- Home
- EVH
as 04-23-2025 4:00pm EST
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | ARLINGTON |
| Market Cap: | 1.2B | IPO Year: | 2015 |
| Target Price: | $16.64 | AVG Volume (30 days): | 2.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.81 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.35 - $33.63 | Next Earning Date: | 05-08-2025 |
| Revenue: | $2,554,741,000 | Revenue Growth: | 30.09% |
| Revenue Growth (this year): | -18.15% | Revenue Growth (next year): | 16.02% |
Stock Insider Trading Activity of Evolent Health Inc (EVH)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| KECK KIM | EVH | Director | Mar 7 '25 | Buy | $9.44 | 10,540 | $99,497.60 | 39,522 | |
| Jelinek Richard M | EVH | Director | Mar 7 '25 | Buy | $9.13 | 30,000 | $273,750.00 | 15,000 | |
| Springstubb Brendan B | EVH | Director | Mar 7 '25 | Buy | $9.27 | 15,000 | $139,050.00 | 26,842 | |
| Barbarosh Craig A. | EVH | Director | Mar 6 '25 | Buy | $8.81 | 2,000 | $17,620.00 | 31,956 | |
| Glass Russell Monroe | EVH | Director | Mar 6 '25 | Buy | $9.27 | 5,400 | $50,058.00 | 14,272 | |
| Blackley Seth | EVH | Chief Executive Officer | Mar 6 '25 | Buy | $9.01 | 55,225 | $497,577.25 | 762,217 | |
| McCarthy Daniel Joseph | EVH | PRESIDENT | Mar 6 '25 | Buy | $9.01 | 11,040 | $99,470.40 | 389,004 | |
| Holder Diane | EVH | Director | Mar 6 '25 | Buy | $9.33 | 2,735 | $25,517.55 | 70,584 | |
| GRUA PETER J | EVH | Director | Mar 6 '25 | Buy | $9.01 | 11,040 | $99,470.40 | 18,749 | |
| Springstubb Brendan B | EVH | Director | Mar 3 '25 | Buy | $8.75 | 5,000 | $43,750.00 | 26,842 |
Latest Evolent Health Inc News
EVH Breaking Stock News: Dive into EVH Ticker-Specific Updates for Smart Investing
Argus Research
a day ago
Daily – Vickers Top Insider Picks for 04/23/2025
Argus Research
2 days ago
Daily – Vickers Top Insider Picks for 04/22/2025
PR Newswire
2 days ago
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors
StockStory
3 days ago
Molina Healthcare, Encompass Health, RadNet, Evolent Health, and Ibotta Shares Are Falling, What You Need To Know
Argus Research
3 days ago
Daily – Vickers Top Insider Picks for 04/21/2025
Argus Research
6 days ago
Daily – Vickers Top Insider Picks for 04/18/2025
Simply Wall St.
7 days ago
Evolent Health Insiders Placed Bullish Bets Worth US$1.35m
Argus Research
7 days ago
Daily – Vickers Top Insider Picks for 04/17/2025
Compare EVH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EVH Evolent Health Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.